Furthermore, the group identified that MEK-ERK1/2 activation led to increase transcription factor FOSL1 activity, a critical component of glioblastoma mesenchymal transformation and cancer aggressiveness [108]. This evidence concerns the gene MAPK3 and glioblastoma.